<p><b>Pharma &amp; Biotech Daily</b> is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.</p><p>Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.</p><p>Produced by <b>OWITH.ai</b>, a boutique AI &amp; data studio.<br> <b>Sponsor the show:</b> <a href="https://sponsor.owith.ai">https://sponsor.owith.ai</a></p>

Subscribe

Title Date published
Strategic Acquisitions and AI Revolutionize Pharma Landscape 2025-10-23
Industry Shifts: Novo Nordisk's Revamp & ADC Breakthroughs 2025-10-22
Transformative Advances in Precision Oncology and ADCs 2025-10-21
Transformative Oncology Breakthroughs and Regulatory Shifts 2025-10-20
Week in review October 18th 2025 2025-10-18
Biotech Breakthroughs: Partnerships, AI, and Clinical Triumphs 2025-10-17
Pharma Breakthroughs: Advancing Cancer, Diabetes, and HIV Care 2025-10-16
Navigating Regulatory Shifts and Strategic Mergers in Biotech 2025-10-15
Revolutionizing Care: Key Biotech Breakthroughs and Trends 2025-10-14
Pharma and Biotech Daily: Keeping You Informed on FDA Approvals, Breakthroughs, and More 2025-10-13
Week in Review - October 10, 2025 2025-10-12
Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates 2025-10-10
Pharma and Biotech Daily: Top Stories in the Industry from Zenas to Lilly 2025-10-09
Pharma and Biotech Daily: Tariff Impact, Promising Trials, and Industry Leaders 2025-10-08
Pharma and Biotech Daily: The Latest in Cell and Gene Therapy, M&A Activity, and Regulatory Updates 2025-10-07
The Essential Updates in Pharma and Biotech: Your Daily Dose of What Matters 2025-10-06
Pharma and Biotech Daily: Top Stories from the Industry 2025-10-03
Pharma and Biotech Daily: Navigating Industry Shifts and Emerging Trends 2025-10-02
Pharma and Biotech Daily: Metsera's Mid-Stage Success, AI in Drug Production, and GSK's CEO Resignation 2025-10-01
Pharma and Biotech Daily: Genmab Acquires Merus, GSK CEO Steps Down, FDA Transparency Concerns, and More! 2025-09-30
1234567

Comments about Pharma and BioTech Daily

comments powered by Disqus
Advertisment: